Alseres Pharmaceuticals Inc (ALSE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-1998 | 12-1997 | 09-1997 | 06-1997 | 03-1997 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,500 | 1,714 | 4,156 | 4,730 | 6,643 |
| Marketable Securities | 10,530 | 12,338 | 11,950 | 13,443 | 13,604 |
| Other current assets | 640 | 659 | 258 | 140 | 169 |
| TOTAL | $12,670 | $14,711 | $16,364 | $18,313 | $20,416 |
| Non-Current Assets | |||||
| PPE Net | N/A | 95 | 236 | 212 | 204 |
| Other Non-Current Assets | 3,770 | 0 | 0 | 0 | 0 |
| TOTAL | $3,770 | $95 | $236 | $212 | $204 |
| Total Assets | $16,520 | $18,579 | $20,071 | $22,013 | $24,128 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,520 | 0 | 0 | 0 | 0 |
| TOTAL | $1,520 | $1,992 | $1,445 | $1,445 | $1,696 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,520 | $1,992 | $1,445 | $1,445 | $1,696 |
| Shareholders' Equity | |||||
| Common Shares | 130 | 130 | 126 | 125 | 1,239 |
| Retained earnings | -34,910 | N/A | N/A | N/A | N/A |
| Other shareholders' equity | 20 | 16,457 | 18,500 | 20,442 | 21,193 |
| TOTAL | $14,990 | $16,587 | $18,626 | $20,567 | $22,432 |
| Total Liabilities And Equity | $16,510 | $18,579 | $20,071 | $22,012 | $24,128 |